Author

S. Satoskar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Satoskar· 2 shared C. Meneses· 2 shared G. Matlashewski· 2 shared G. Volpedo· 2 shared H. L. Nakhasi· 2 shared J. G. Valenzuela· 2 shared J. Oristian· 2 shared M. Satoskar· 2 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Satoskar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Preclinical validation of a second generation leishmanization vaccine against vector transmitted fatal visceral leishmaniasis

H. L. Nakhasi, R. DEY, S. Gannavaram, S. Karmakar, P. Bhattacharya, N. Ismail, A. Satoskar, G. Volpedo, L. F. Oliveira, J. Oristian, C. Meneses, J. G. Valenzuela, S. Kamhawi, W. W. Zhang, G. Matlashewski, , K. Pandey

This study evaluates the protective efficacy of a CRISPR-edited Leishmania major strain against visceral leishmaniasis in hamsters and shows it induces a pro-inflammatory immune response and prevents disease.

bioRxiv · Nov 18, 2020Immunology

A Second Generation Leishmanization Vaccine with a Markerless Attenuated Leishmania major Strain using CRISPR gene editing

W. W. Zhang, S. Karmakar, S. Gannavaram, R. Dey, P. Lypaczewski, N. Ismail, A. Siddiqui, V. Simonyan, F. Oliveira, I. V. Coutinho-Abreu, T. DeSouza-Vieira, C. Meneses, J. Oristian, T. D. Serfim, A. Musa, , H. L. Nakhasi

This paper describes a CRISPR-edited Leishmania major strain for a second-generation leishmanization vaccine that is marker-free and safe, showing protection in mice comparable to traditional leishmanization.

bioRxiv · May 4, 2020Microbiology